D.E. Shaw & Co’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.45M | Buy |
194,528
+185,752
| +2,117% | +$8.07M | 0.01% | 1151 |
|
2025
Q1 | $328K | Sell |
8,776
-1,037
| -11% | -$38.7K | ﹤0.01% | 2625 |
|
2024
Q4 | $445K | Sell |
9,813
-39,849
| -80% | -$1.81M | ﹤0.01% | 2451 |
|
2024
Q3 | $2.92M | Sell |
49,662
-2,364
| -5% | -$139K | ﹤0.01% | 1596 |
|
2024
Q2 | $2.05M | Buy |
+52,026
| New | +$2.05M | ﹤0.01% | 1791 |
|